|
Regulation of Transforming Growth Factor β-Activated Kinase Activation by Epigallocatechin-3-Gallate in Rheumatoid Arthritis Synovial Fibroblasts: Suppression of K 63 -Linked Autoubiquitination of Tumor Necrosis Factor Receptor-Associated Factor 6: TAK1 INHIBITION BY EGCG IN RA
|
journal
|
January 2016 |
|
Identification of Aminoimidazole and Aminothiazole Derivatives as Src Family Kinase Inhibitors
|
journal
|
October 2015 |
|
TAK1-mediated stress signaling pathways are essential for TNF-α-promoted pulmonary metastasis of murine colon cancer cells
|
journal
|
January 2006 |
|
TNF-mediated inflammatory disease
|
journal
|
January 2008 |
|
NF-κB in colorectal cancer
|
journal
|
May 2013 |
|
TAK1 regulates hepatic cell survival and carcinogenesis
|
journal
|
January 2014 |
|
Isolated Limb Perfusion with Melphalan and TNF-α in the Treatment of Extremity Sarcoma
|
journal
|
December 2007 |
|
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
|
journal
|
May 1976 |
|
Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells
|
journal
|
October 1994 |
|
Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4
|
journal
|
June 2006 |
|
TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers
|
journal
|
February 2012 |
|
Optical and Radioiodinated Tethered Hsp90 Inhibitors Reveal Selective Internalization of Ectopic Hsp90 in Malignant Breast Tumor Cells
|
journal
|
September 2013 |
|
Identification of an Allosteric Small-Molecule Inhibitor Selective for the Inducible Form of Heat Shock Protein 70
|
journal
|
December 2014 |
|
Fasnall, a Selective FASN Inhibitor, Shows Potent Anti-tumor Activity in the MMTV-Neu Model of HER2 + Breast Cancer
|
journal
|
June 2016 |
|
Treatment modifications in tumour necrosis factor-α (TNF)-based isolated limb perfusion in patients with advanced extremity soft tissue sarcomas
|
journal
|
February 2015 |
|
TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling
|
journal
|
October 2004 |
|
Efficacy, safety and pharmacokinetics of biosimilars of anti-tumor necrosis factor-α agents in rheumatic diseases; A systematic review and meta-analysis
|
journal
|
May 2017 |
|
Targeting of TAK1 in inflammatory disorders and cancer
|
journal
|
October 2012 |
|
Mechanism and In Vitro Pharmacology of TAK1 Inhibition by (5 Z )-7-Oxozeaenol
|
journal
|
January 2013 |
|
Fluorescence Linked Enzyme Chemoproteomic Strategy for Discovery of a Potent and Selective DAPK1 and ZIPK Inhibitor
|
journal
|
October 2013 |
|
Discovery of Type II Inhibitors of TGFβ-Activated Kinase 1 (TAK1) and Mitogen-Activated Protein Kinase Kinase Kinase Kinase 2 (MAP4K2)
|
journal
|
July 2014 |
|
Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis
|
journal
|
July 1999 |
|
IRAK signalling in cancer
|
journal
|
October 2014 |
|
A conserved water-mediated hydrogen bond network defines bosutinib's kinase selectivity
|
journal
|
December 2013 |
|
Profiling drugs for rheumatoid arthritis that inhibit synovial fibroblast activation
|
journal
|
October 2016 |
|
Assay of protein kinases using radiolabeled ATP: a protocol
|
journal
|
August 2006 |
|
The druggable genome
|
journal
|
September 2002 |
|
MUC1-C activates the TAK1 inflammatory pathway in colon cancer
|
journal
|
February 2015 |
|
Tumor necrosis factor signaling
|
journal
|
January 2003 |
|
Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer
|
journal
|
November 2001 |
|
TAK1 is required for TGF-β1-mediated regulation of matrix metalloproteinase-9 and metastasis
|
journal
|
September 2007 |
|
TAK1 inhibitor NG25 enhances doxorubicin-mediated apoptosis in breast cancer cells
|
journal
|
September 2016 |
|
The contents of adenine nucleotides, phosphagens and some glycolytic intermediates in resting muscles from vertebrates and invertebrates
|
journal
|
October 1975 |
|
Characterization of a UBC13 kinase in Plasmodium falciparum
|
journal
|
April 2007 |
|
Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis
|
journal
|
December 2009 |
|
Ubiquitin-conjugating enzyme Ubc13 controls breast cancer metastasis through a TAK1-p38 MAP kinase cascade
|
journal
|
September 2014 |
|
TAK1 Mitogen-activated Protein Kinase Kinase Kinase Is Activated by Autophosphorylation within Its Activation Loop
|
journal
|
March 2000 |
|
Autoactivation of Transforming Growth Factor β-activated Kinase 1 Is a Sequential Bimolecular Process
|
journal
|
August 2010 |
|
Cellular Localization of Tumor Necrosis Factor- α Following Acute Spinal Cord Injury in Adult Rats
|
journal
|
May 2001 |
|
Phase I Study of a Combination of Recombinant Tumor Necrosis Factor-α and Recombinant Interferon-γ in Cancer Patients
|
journal
|
August 1989 |
|
Breast Tumor Cell Lines From Pleural Effusions2
|
journal
|
September 1974 |
|
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions
|
journal
|
January 1995 |
|
Remission in ankylosing spondylitis treated with anti-TNF- drugs: a national multicentre study
|
journal
|
July 2013 |
|
TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo
|
journal
|
November 2005 |
|
Coot model-building tools for molecular graphics
|
journal
|
November 2004 |
|
HKL -3000: the integration of data reduction and structure solution – from diffraction images to an initial model in minutes
|
journal
|
July 2006 |
|
PHENIX: a comprehensive Python-based system for macromolecular structure solution
|
journal
|
January 2010 |
|
REFMAC 5 for the refinement of macromolecular crystal structures
|
journal
|
March 2011 |
|
Localization of tumour necrosis factor-alpha (TNF-α) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor
|
journal
|
November 1993 |
|
A Kinetic Test Characterizes Kinase Intramolecular and Intermolecular Autophosphorylation Mechanisms
|
journal
|
July 2013 |
|
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
|
journal
|
March 2013 |
|
p38 Mitogen-Activated Protein Kinase Promotes Cell Survival in Response to DNA Damage but Is Not Required for the G2 DNA Damage Checkpoint in Human Cancer Cells
|
journal
|
June 2010 |
|
NF-κB Inducers Upregulate cFLIP, a Cycloheximide-Sensitive Inhibitor of Death Receptor Signaling
|
journal
|
June 2001 |
|
Identification of genomic targets downstream of p38 mitogen-activated protein kinase pathway mediating tumor necrosis factor-α signaling
|
journal
|
October 2007 |
|
TAK1–TAB2 Signaling Contributes to Bone Destruction by Breast Carcinoma Cells
|
journal
|
June 2011 |
|
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
|
journal
|
May 2012 |
|
Avogadro: an advanced semantic chemical editor, visualization, and analysis platform
|
journal
|
August 2012 |
|
Pulmonary Toxicity of Recombinant Human Tumor Necrosis Factor
|
journal
|
August 1989 |
|
Targeting of TGF-β-activated protein kinase 1 inhibits chemokine (C-C motif) receptor 7 expression, tumor growth and metastasis in breast cancer
|
journal
|
December 2014 |
|
The Purinome, a Complex Mix of Drug and Toxicity Targets
|
journal
|
June 2006 |
|
Molecular Interactions between T Cells and Fibroblast-Like Synoviocytes
|
journal
|
November 2007 |
|
Post-Translational Modifications of the TAK1-TAB Complex
|
journal
|
January 2017 |
|
TAK1 selective inhibition: state of the art and future opportunities
|
journal
|
January 2015 |